Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RJF
RJF logo

RJF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Raymond James Financial Inc (RJF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
152.240
1 Day change
0.32%
52 Week Range
177.660
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Raymond James Financial Inc (RJF) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company's fundamentals show resilience in revenue growth, the decline in net income and EPS, coupled with insider selling and neutral hedge fund activity, suggest caution. Additionally, the lack of strong trading signals or positive news catalysts further supports a hold recommendation.

Technical Analysis

The MACD is positive and contracting, indicating a potential upward momentum. RSI is neutral at 56.976, suggesting no overbought or oversold conditions. Moving averages are converging, and the stock is trading near its pivot point of 147.881 with resistance at 154.807 and support at 140.954. Overall, the technical indicators are neutral to slightly positive but not strongly bullish.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a slightly bullish sentiment in the options market, but the implied volatility percentile at 80 suggests elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
7

Positive Catalysts

  • The company's revenue increased by 3.27% YoY, and gross margin improved by 2.06% YoY, showing operational efficiency. Analysts from Barclays and BofA remain optimistic about the company's long-term growth potential.

Neutral/Negative Catalysts

  • Net income dropped by 6.19% YoY, and EPS fell by 2.45% YoY, indicating declining profitability. Insider selling has increased by 448.35% over the last month, and hedge funds remain neutral. Analysts have lowered price targets across the board, reflecting cautious sentiment.

Financial Performance

In Q1 2026, revenue grew to $4.08 billion, up 3.27% YoY, but net income dropped to $561 million, down 6.19% YoY. EPS declined to 2.79, down 2.45% YoY, while gross margin improved to 89.19%, up 2.06% YoY. The financials show mixed performance with growth in revenue but declining profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have consistently lowered price targets recently, with the latest targets ranging from $145 to $174. Ratings are mostly Neutral or Hold, with only Barclays maintaining an Overweight rating. This reflects cautious sentiment and limited near-term upside.

Wall Street analysts forecast RJF stock price to rise
9 Analyst Rating
Wall Street analysts forecast RJF stock price to rise
2 Buy
7 Hold
0 Sell
Hold
Current: 152.240
sliders
Low
176
Averages
184
High
196
Current: 152.240
sliders
Low
176
Averages
184
High
196
Morgan Stanley
Michael Cyprys
Equal Weight
downgrade
$187 -> $171
AI Analysis
2026-04-10
Reason
Morgan Stanley
Michael Cyprys
Price Target
$187 -> $171
AI Analysis
2026-04-10
downgrade
Equal Weight
Reason
Morgan Stanley analyst Michael Cyprys lowered the firm's price target on Raymond James to $171 from $187 and keeps an Equal Weight rating on the shares. Better Q1 earnings for brokers and exchanges should modestly beat consensus, but the firm sees modest forward estimate risk and notes in a preview for the group that its forecasts for the group are now 4%-5% below consensus in 2026-27 on average.
TD Cowen
Hold
downgrade
$181 -> $156
2026-04-09
Reason
TD Cowen
Price Target
$181 -> $156
2026-04-09
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Raymond James to $156 from $181 and keeps a Hold rating on the shares. The firm adjusted targets in the asset manager, broker dealers and exchanges group as part of a Q1 preview.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RJF
Unlock Now

People Also Watch